Lilly stated “There will be no price reduction on Cialis,” focusing its business on urology clinics

While about 50 domestic companies are expected to launch Cialis generics on the 4^th of September, Lilly owning Cialis announced it would not carry out a policy to cut its drug price.

Particularly, as it ended the co-promotion relationship with Handok, Lilly has been planning to focus on business activities targeting general hospitals and to concentrate on activities towards urology clinics by ...